Research output per year
Research output per year
Personal profile
Biography
Dr. Waterman is an infectious disease clinician, researcher, and leader in the battle against antimicrobial resistant bacteria (AMR). Dr. Waterman has worked across clinical, R&D, and policy settings to curb rising drug resistance through surveillance and early detection of emerging pathogens. She is a proponent for using biotechnology and big data to promote, protect, and respond to various disease threats. Upon her retirment from active duty service, Dr. Waterman assumed the role of Vice Chair for Clinical Research at USUHS and is currently the Interim Chair of Medicine at USUHS.
Education/Academic qualification
Medicine
Award Date: 17 May 2003
External positions
Awards Committee, ACP, DC Chapter
2022 → …
Volunteer, Maryland Reserve Corps
2020 → …
ASTMH Ben Kean Committee Member
2018 → …
Steering Committee (AMR) member, Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS)
2015 → …
Steering Committee (wound infections) member, MIDRP
2015 → …
Special Govt Employee (ex officio), PACCARB
2015 → …
DOD Rep, CARB Task Force
2014 → …
Fingerprint
Dive into the research topics where Paige Waterman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A panel of diverse Klebsiella pneumoniae clinical isolates for research and development
Martin, M. J., Stribling, W., Ong, A. C., Maybank, R., Kwak, Y. I., Rosado-Mendez, J. A., Preston, L. N., Lane, K. F., Julius, M., Jones, A. R., Hinkle, M., Waterman, P. E., Lesho, E. P., Lebreton, F., Bennett, J. W. & Mc Gann, P. T., 1 May 2023, In: Microbial Genomics. 9, 5, 000967.Research output: Contribution to journal › Article › peer-review
Open Access -
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
RV 507 Study Team, 28 Jan 2023, In: The Lancet. 401, 10373, p. 294-302 9 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development
Lebreton, F., Snesrud, E., Hall, L., Mills, E., Galac, M., Stam, J., Ong, A., Maybank, R., Kwak, Y. I., Johnson, S., Julius, M., Ly, M., Swierczewski, B., Waterman, P. E., Hinkle, M., Jones, A., Lesho, E., Bennett, J. W. & Mcgann, P., 1 Dec 2021, In: JAC-Antimicrobial Resistance. 3, 4, dlab179.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials
Dulin, N., Spanier, A., Merino, K., Hutter, J. N., Waterman, P. E., Lee, C. & Hamer, M. J., 8 Jan 2021, In: Vaccine. 39, 2, p. 202-208 7 p.Research output: Contribution to journal › Review article › peer-review
19 Scopus citations -
A diverse panel of clinical acinetobacter baumannii for research and development
Galac, M. R., Snesrud, E., Lebreton, F., Stam, J., Julius, M., Ong, A. C., Maybank, R., Jones, A. R., Kwak, Y. I., Hinkle, K., Waterman, P. E., Lesho, E. P., Bennett, J. W. & Gann, P. M., Oct 2020, In: Antimicrobial Agents and Chemotherapy. 64, 10, e00840.Research output: Contribution to journal › Article › peer-review
26 Scopus citations
Press/Media
-
Dr. Paige Waterman Named New Medicine Chair at the Uniformed Services University
20/09/23
1 item of Media coverage
Press/Media
-
Marburg Vaccine Breakthrough: First Human Study Shows Promising Results
4/02/23 → 5/02/23
2 items of Media coverage
Press/Media
-
Center for Strategic & International Studies: U.S. Government and Antimicrobial Resistance
10/06/20
1 item of Media coverage
Press/Media